Alimera Sciences Inc (NASDAQ:ALIM)
| 3.36 Delayed Data As of Dec 01 |  +0.275 / +8.91%Today’s Change | 1.30 Today|||52-Week Range 3.90 | +23.99% Year-to-Date |
Latest ALIM News | Press Releases
No recent news for Alimera Sciences Inc.
Today’s Trading
| Previous close | 3.09 |
| Today’s open | 3.25 |
| Day’s range | 3.25 - 3.36 |
| Volume | 435 |
| Average volume (3 months) | 35,756 |
| Market cap | $182.9M |
Data as of 3:59pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | -290.39% |
| Earnings growth (this year) | +98.65% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -8.30% |
| P/E ratio | NM |
| Price/Sales | 0.35 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Ecogreen Internation... | 0.00 | 0.00% |
| PDSBPDS Biotechnology Co... | -0.01 | -0.19% |
| GNFTGenfit SA | 0.00 | 0.00% |
| STROSutro Biopharma Inc | +0.15 | +5.75% |
Data as of 4:00pm ET, 12/01/2023
Financials
| Next reporting date | February 21, 2024 |
| EPS forecast (this quarter) | $0.05 |
| Annual revenue (last year) | $54.1M |
| Annual profit (last year) | -$18.1M |
| Net profit margin | -33.45% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Alpharetta, Georgia |
Forecasts
